Fábio S Lira1, Barbara de M M Antunes, Marília Seelaender, José C Rosa Neto. 1. aExercise and Immunometabolism Research Group, Department of Physical Education, São Paulo State University (UNESP), Presidente Prudente bDepartment of Surgery, Faculdade de Medicina, Cancer Metabolism Research Group cImmunometabolism Research Group, Institute of Biomedical Sciences, University of São Paulo (USP), São Paulo, SP, Brazil.
Abstract
PURPOSE OF REVIEW: To discuss the role of physical exercise in the attenuation of cancer cachexia-associated symptoms, and upon the outcome of chemotherapy, with special focus on the anti-inflammatory role of chronic exercise. RECENT FINDINGS: The review addresses the recent findings regarding the positive effects of endurance and strength exercise training upon metabolic dysfunction, systemic inflammation and body composition alterations in the syndrome of cachexia. The employment of different exercise protocol strategies, in respect to intensity, duration, work load and in concomitance with pharmacological treatment is considered. SUMMARY: Cachexia is a multifactorial wasting syndrome afflicting patients with cancer, chronic obstructive pulmonary disease, chronic heart failure, trauma, among other diseases. This condition markedly compromises the quality of life, treatment outcome and survival. Recent literature indicates an unequivocal role of chronic exercise in modulating cachexia and other cancer-associated dysfunctions. Exercise is proposed as a complementary treatment in cancer, and represents a function-preserving, anti-inflammatory and metabolism-modulating strategy with low cost, and high versatility and availability. Furthermore, exercise decreases cancer recurrence and presents a positive impact on public health management, reducing hospitalization and medication costs.
PURPOSE OF REVIEW: To discuss the role of physical exercise in the attenuation of cancer cachexia-associated symptoms, and upon the outcome of chemotherapy, with special focus on the anti-inflammatory role of chronic exercise. RECENT FINDINGS: The review addresses the recent findings regarding the positive effects of endurance and strength exercise training upon metabolic dysfunction, systemic inflammation and body composition alterations in the syndrome of cachexia. The employment of different exercise protocol strategies, in respect to intensity, duration, work load and in concomitance with pharmacological treatment is considered. SUMMARY:Cachexia is a multifactorial wasting syndrome afflicting patients with cancer, chronic obstructive pulmonary disease, chronic heart failure, trauma, among other diseases. This condition markedly compromises the quality of life, treatment outcome and survival. Recent literature indicates an unequivocal role of chronic exercise in modulating cachexia and other cancer-associated dysfunctions. Exercise is proposed as a complementary treatment in cancer, and represents a function-preserving, anti-inflammatory and metabolism-modulating strategy with low cost, and high versatility and availability. Furthermore, exercise decreases cancer recurrence and presents a positive impact on public health management, reducing hospitalization and medication costs.
Authors: José Gerosa-Neto; Barbara M M Antunes; Eduardo Z Campos; Jhennyfer Rodrigues; Gustavo D Ferrari; José C Rosa Neto; Carlos R Bueno; Fábio S Lira Journal: J Exerc Rehabil Date: 2016-12-31
Authors: Bruna S de Alencar Silva; Fábio S Lira; Fabrício E Rossi; Dionei Ramos; Juliana S Uzeloto; Ana P C F Freire; Fabiano F de Lima; Luís A Gobbo; Ercy M C Ramos Journal: Front Physiol Date: 2018-03-23 Impact factor: 4.566
Authors: Martina Ferioli; Giorgio Zauli; Alberto M Martelli; Marco Vitale; James A McCubrey; Simona Ultimo; Silvano Capitani; Luca M Neri Journal: Oncotarget Date: 2018-02-08
Authors: Andrea D Re Cecconi; Mara Forti; Michela Chiappa; Zhiyong Zhu; Leonid V Zingman; Luigi Cervo; Luca Beltrame; Sergio Marchini; Rosanna Piccirillo Journal: Cancers (Basel) Date: 2019-10-12 Impact factor: 6.639
Authors: Sara Peixoto da Silva; Joana M O Santos; Maria Paula Costa E Silva; Rui M Gil da Costa; Rui Medeiros Journal: J Cachexia Sarcopenia Muscle Date: 2020-03-06 Impact factor: 12.910